Tag: Radiation Therapy
-
Joe Biden Undergoes Radiation and Hormone Therapy for Aggressive Prostate Cancer
Overview of Biden’s Updated Cancer Treatment Former President Joe Biden is in a new phase of treatment for an aggressive form of prostate cancer. His spokesperson confirmed that he is undergoing radiation therapy along with hormone treatment as part of a comprehensive treatment plan. This marks a shift from previous management to a combined approach…
-
Biden Undergoes Radiation Therapy for Prostate Cancer: What This Means
Overview: Biden’s Cancer Care Update Former U.S. President Joe Biden is receiving radiation therapy as part of his treatment for prostate cancer, his spokesman confirmed. The 82-year-old is also undergoing hormone treatment, though officials did not disclose additional medical specifics. The radiation course is expected to last five weeks, marking a new phase in his…
-
Joe Biden Prostate Cancer: Radiation Therapy and Hormone Treatment
Update on Joe Biden’s Prostate Cancer Treatment Former president Joe Biden is undergoing a new phase in his cancer care, his spokesperson has confirmed. After revealing earlier this year that he has an aggressive form of prostate cancer, Biden’s treatment plan has evolved to include radiation therapy combined with hormone treatment. The five-week radiation course…
-
Joe Biden Prostate Cancer: Radiation Therapy Update
A new phase in treatment for Joe Biden Former U.S. president Joe Biden has entered a new phase of treatment for his prostate cancer, following his May revelation that he has an aggressive form of the disease. A spokesperson confirmed he is now receiving radiation therapy along with hormone treatment as part of an overall…
-
Avelumab and Radiation Show Promise for Leptomeningeal Disease
Promising early results for avelumab plus radiation in leptomeningeal disease In a small but encouraging phase 1B study, researchers at Moffitt Cancer Center report that the immunotherapy drug avelumab, when given with whole-brain radiotherapy, may offer a new, potentially safer and more effective option for leptomeningeal disease (LMD). The findings, published in Neuro-Oncology, come from…
-
Avelumab with Radiation for Leptomeningeal Disease: Momentum
Introduction Leptomeningeal disease, in which cancer cells invade the membranes surrounding the brain and spinal cord, remains one of oncology’s most daunting challenges. Patients face rapid neurological decline, and survival is often measured in weeks to months. In a phase 1B study from Moffitt Cancer Center, researchers explored whether combining the immunotherapy drug avelumab with…
-
Avelumab with Radiation: Hope for Leptomeningeal Disease
Leptomeningeal disease: a high-stakes challenge in oncology Leptomeningeal disease, where cancer cells spread to the membranes surrounding the brain and spinal cord, remains one of oncology’s most formidable complications. Patients diagnosed with this condition often face survival measured in weeks to months, and treatment options are historically limited. In a hopeful development, researchers at Moffitt…
-
Radiopharmaceutical Therapy Boosts Radiation, Slows Prostate Cancer
What the LUNAR trial tested SAN FRANCISCO, September 28, 2025 — A new phase II clinical trial, called LUNAR, shows that adding a radiopharmaceutical drug before high-precision radiation therapy can help people with a limited number of metastatic lesions from recurrent prostate cancer live longer without disease progression. In this randomized study, patients received either…
-
Radiopharmaceutical Therapy Boosts Radiation to Slow Prostate Cancer
New Findings from the LUNAR Trial A landmark phase II study, known as the LUNAR trial, reports that people with recurrent prostate cancer and a limited number of metastases lived significantly longer without disease progression when a radiopharmaceutical drug was given before targeted radiation therapy, compared with high-precision radiation alone. The randomized study evaluated whether…